These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12395996)

  • 21. Treatment strategies for gastroesophageal reflux disease.
    Humphries TJ
    Clin Ther; 2000 Dec; 22(12):1590-1. PubMed ID: 11192149
    [No Abstract]   [Full Text] [Related]  

  • 22. The basis of differentiation of PPIs.
    Sachs G; Shin JM
    Drugs Today (Barc); 2004 Mar; 40 Suppl A():9-14. PubMed ID: 15190382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of pantoprazole in the treatment of gastro-oesophageal reflux disease.
    Lehmann FS; Beglinger C
    Expert Opin Pharmacother; 2005 Jan; 6(1):93-104. PubMed ID: 15709887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of medical therapy and antireflux surgery on dysphagia in patients with gastroesophageal reflux disease without esophageal stricture.
    Wetscher GJ; Glaser K; Gadenstaetter M; Profanter C; Hinder RA
    Am J Surg; 1999 Mar; 177(3):189-92. PubMed ID: 10219852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pantoprazole, Prout and the proton pump.
    Playford RJ; Podas T; Modlin I
    Hosp Med; 1999 Jul; 60(7):500-4. PubMed ID: 10605542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early relief of upper gastrointestinal dyspeptic symptoms: a survey of empirical therapy with pantoprazole in Canadian clinical practice.
    Armstrong D; Kazim F; Gervais M; Pyzyk M
    Can J Gastroenterol; 2002 Jul; 16(7):439-50. PubMed ID: 12177723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of aggressive therapy on laryngeal symptoms and voice characteristics in patients with gastroesophageal reflux.
    Hamdan AL; Sharara AI; Younes A; Fuleihan N
    Acta Otolaryngol; 2001 Oct; 121(7):868-72. PubMed ID: 11718254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux.
    Wo JM; Koopman J; Harrell SP; Parker K; Winstead W; Lentsch E
    Am J Gastroenterol; 2006 Sep; 101(9):1972-8; quiz 2169. PubMed ID: 16968502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pantoprazole for sleepiness associated with acid reflux and obstructive sleep disordered breathing.
    Steward DL
    Laryngoscope; 2004 Sep; 114(9):1525-8. PubMed ID: 15475774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacology and clinical relevance of proton pump inhibitors.
    Katz PO; Frissora C
    Curr Gastroenterol Rep; 2002 Dec; 4(6):459-62. PubMed ID: 12441035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of oral pantoprazole 20 mg given once daily for reflux esophagitis in children.
    Madrazo-de la Garza A; Dibildox M; Vargas A; Delgado J; Gonzalez J; Yañez P
    J Pediatr Gastroenterol Nutr; 2003 Feb; 36(2):261-5. PubMed ID: 12548064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton pump inhibitors.
    Grover JK; Vats V
    Trop Gastroenterol; 1999; 20(1):16-28. PubMed ID: 10464444
    [No Abstract]   [Full Text] [Related]  

  • 33. Dose-dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers.
    Tutuian R; Katz PO; Bochenek W; Castell DO
    Aliment Pharmacol Ther; 2002 Apr; 16(4):829-36. PubMed ID: 11929403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. pH probe positioning for 24-hour pH-metry by manometry or pH step-up.
    Pehl C; Boccali I; Hennig M; Schepp W
    Eur J Gastroenterol Hepatol; 2004 Apr; 16(4):375-82. PubMed ID: 15028969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relapse prevention in reflux oesophagitis with regard to Helicobacter pylori status: a double-blind, randomized, multicentre trial to compare the efficacy of pantoprazole versus ranitidine.
    Adamek RJ; Behrendt J; Wenzel C
    Eur J Gastroenterol Hepatol; 2001 Jul; 13(7):811-7. PubMed ID: 11474311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pantoprazole 20 mg on demand is effective in the long-term management of patients with mild gastro-oesophageal reflux disease.
    Kaspari S; Kupcinskas L; Heinze H; Berghöfer P
    Eur J Gastroenterol Hepatol; 2005 Sep; 17(9):935-41. PubMed ID: 16093871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome.
    Ramdani A; Mignon M; Samoyeau R
    Gastroenterol Clin Biol; 2002 Apr; 26(4):355-9. PubMed ID: 12070410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Twenty-four-hour monitoring of intragastric acidity: comparison between lansoprazole 30mg and pantoprazole 40mg.
    Florent C; Forestier S
    Eur J Gastroenterol Hepatol; 1997 Feb; 9(2):195-200. PubMed ID: 9058634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole.
    Holtmann G; Cain C; Malfertheiner P
    Gastroenterology; 1999 Jul; 117(1):11-6. PubMed ID: 10381904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study.
    Kovacs TO; Wilcox CM; DeVault K; Miska D; Bochenek W;
    Aliment Pharmacol Ther; 2002 Dec; 16(12):2043-52. PubMed ID: 12452936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.